{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T06:10:49Z","timestamp":1687932649163},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"DOI":"10.1007\/s12311-022-01447-8","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T10:03:08Z","timestamp":1658829788000},"page":"534-541","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Ataxia: Antibodies at the Forefront Have Become Routine Biomarkers"],"prefix":"10.1007","volume":"22","author":[{"given":"Lazaros C.","family":"Triarhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Manto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"1447_CR1","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"PRB Darnell","year":"2003","unstructured":"Darnell PRB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349:1543\u201354.","journal-title":"N Engl J Med"},{"key":"1447_CR2","first-page":"265","volume-title":"The cerebellum and its disorders","author":"J Hildebrand","year":"2002","unstructured":"Hildebrand J, Bal\u00e9riaux D. Cerebellar disorders in cancer. In: Manto M, Pandolfo M, editors. The cerebellum and its disorders. Cambridge, UK: Cambridge University Press; 2002. p. 265\u201387."},{"key":"1447_CR3","first-page":"199","volume":"156","author":"JE Greenlee","year":"1992","unstructured":"Greenlee JE, Brashear HR, Jaeckle KA, Geleris A, Jordan K. Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies: need for vigorous follow-up. West J Med. 1992;156:199\u2013202.","journal-title":"West J Med"},{"key":"1447_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/978-3-030-19515-1_14","volume-title":"Neuroimmune diseases: contemporary clinical neuroscience","author":"S Mu\u00f1iz-Castrillo","year":"2019","unstructured":"Mu\u00f1iz-Castrillo S, Honnorat J. Paraneoplastic neurological syndromes. In: Mitoma H, Manto M, editors. Neuroimmune diseases: contemporary clinical neuroscience. Cham, Switzerland: Springer; 2019. p. 439\u201385."},{"key":"1447_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","volume":"36","author":"MR Roselfeld","year":"2018","unstructured":"Roselfeld MR, Dalmau J. Paraneoplastic cerebellar syndromes. Neurol Clin. 2018;36:675\u201385.","journal-title":"Neurol Clin"},{"key":"1447_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ana.24083","volume":"75","author":"T Armangue","year":"2014","unstructured":"Armangue T, Leypoldt F, M\u00e1laga I, Raspall-Chaure M, Marti I, Nichter C, Pugh J, Vicente-Rasoamalala M, Lafuente-Hidalgo M, Macaya A, Ke M, Titulaer MJ, H\u00f6ftberger R, Sheriff H, Glaser C, Dalmau J. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014;75:317\u201323.","journal-title":"Ann Neurol"},{"key":"1447_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0165-5728(96)00205-6","volume":"74","author":"F Graus","year":"1997","unstructured":"Graus F, Dalmau J, Valldeoriola F, Ferrer I, Re\u00f1e R, Marin C, Vecht CJ, Arbizu T, Targa C, Moll JW. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin\u2019s disease. J Neuroimmunol. 1997;74:55\u201361.","journal-title":"J Neuroimmunol"},{"key":"1447_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJM200001063420104","volume":"342","author":"P Sillevis Smitt","year":"2000","unstructured":"Sillevis Smitt P, Kinoshita A, De Leeuw B, Moll W, Coesmans M, Jaarsma D, Henzen-Logmans S, Vecht C, De Zeeuw C, Sekiyama N, Nakanishi S, Shigemoto R. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N Engl J Med. 2000;342:21\u20137.","journal-title":"N Engl J Med"},{"key":"1447_CR9","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJM199006283222604","volume":"322","author":"HM Furneaux","year":"1990","unstructured":"Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, Posner JB. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med. 1990;322:1844\u201351.","journal-title":"N Engl J Med"},{"key":"1447_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0022-510X(01)00442-7","volume":"184","author":"JE Greenlee","year":"2001","unstructured":"Greenlee JE, Boyden JW, Pingree M, Brashear HR, Clawson SA, Keeney PM. Antibody types and IgG subclasses in paraneoplastic neurological syndromes. J Neurol Sci. 2001;184:131\u20137.","journal-title":"J Neurol Sci"},{"key":"1447_CR11","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/acn3.328","volume":"3","author":"A Venkatraman","year":"2016","unstructured":"Venkatraman A, Opal P. Paraneoplastic cerebellar degeneration with anti-Yo antibodies: a review. Ann Clin Transl Neurol. 2016;3:655\u201363.","journal-title":"Ann Clin Transl Neurol"},{"key":"1447_CR12","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1007\/s00415-021-10934-7","volume":"269","author":"A Sturchio","year":"2022","unstructured":"Sturchio A, Dwivedi AK, Gastaldi M, Grimberg MB, Businaro P, Duque KR, Vizcarra JA, Abdelghany E, Balint B, Marsili L, Espay AJ. Movement disorders associated with neuronal antibodies: a data-driven approach. J Neurol. 2022;269:3511\u201321.","journal-title":"J Neurol"},{"key":"1447_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","volume":"72","author":"H Ari\u00f1o","year":"2015","unstructured":"Ari\u00f1o H, H\u00f6ftberger R, Gresa-Arribas N, Mart\u00ednez-Hern\u00e1ndez E, Armangue T, Kruer MC, Arpa J, Domingo J, Rojc B, Bataller L, Saiz A, Dalmau J, Graus F. Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol. 2015;72:874\u201381.","journal-title":"JAMA Neurol"},{"key":"1447_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-021-01363-3","author":"S Mu\u00f1iz-Castrillo","year":"2022","unstructured":"Mu\u00f1iz-Castrillo S, Vogrig A, Ciano-Petersen NL, Villagr\u00e1n-Garc\u00eda M, Joubert B, Honnorat J. Novelties in autoimmune and paraneoplastic cerebellar ataxias: twenty years of progress. Cerebellum. 2022. https:\/\/doi.org\/10.1007\/s12311-021-01363-3.","journal-title":"Cerebellum"},{"key":"1447_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ana.410140603","volume":"14","author":"JE Greenlee","year":"1983","unstructured":"Greenlee JE, Brashear HR. Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma. Ann Neurol. 1983;14:609\u201313.","journal-title":"Ann Neurol"},{"key":"1447_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1742-2094-6-31","volume":"6","author":"KE Hill","year":"2009","unstructured":"Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE. Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation. 2009;6:31. https:\/\/doi.org\/10.1186\/1742-2094-6-31.","journal-title":"J Neuroinflammation"},{"key":"1447_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12974-014-0160-0","volume":"11","author":"JE Greenlee","year":"2014","unstructured":"Greenlee JE, Clawson SA, Hill KE, Wood B, Clardy SL, Tsunoda I, Jaskowski TD, Carlson NG. Neuronal uptake of anti-Hu antibody, but not anti-Ri antibody, leads to cell death in brain slice cultures. J Neuroinflammation. 2014;11:160. https:\/\/doi.org\/10.1186\/s12974-014-0160-0.","journal-title":"J Neuroinflammation"},{"key":"1447_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/00006250-198812000-00023","volume":"72","author":"R McLellan","year":"1988","unstructured":"McLellan R, Currie JL, Royal W, Rosenshein NB. Ovarian carcinoma and paraneoplastic cerebellar degeneration. Obstet Gynecol. 1988;72:922\u20135.","journal-title":"Obstet Gynecol"},{"key":"1447_CR19","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/WNL.39.12.1605","volume":"39","author":"HR Brashear","year":"1989","unstructured":"Brashear HR, Greenlee JE, Jaeckle KA, Rose JW. Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms. Neurology. 1989;39:1605\u20139.","journal-title":"Neurology"},{"key":"1447_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11940-012-0215-4","volume":"15","author":"JE Greenlee","year":"2013","unstructured":"Greenlee JE. Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol. 2013;15:185\u2013200.","journal-title":"Curr Treat Options Neurol"},{"key":"1447_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3389\/fimmu.2020.00991","volume":"11","author":"L Yshii","year":"2020","unstructured":"Yshii L, Bost C, Liblau R. Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications. Front Immunol. 2020;11:991. https:\/\/doi.org\/10.3389\/fimmu.2020.00991.","journal-title":"Front Immunol"},{"key":"1447_CR22","doi-asserted-by":"publisher","first-page":"E264","DOI":"10.1055\/s-0043-112730","volume":"1","author":"I Ayzenberg","year":"2017","unstructured":"Ayzenberg I, Gold R, Kleiter I. Management of immune-mediated paraneoplastic neurological disorders. Neurol Int Open. 2017;1:E264\u201374. https:\/\/doi.org\/10.1055\/s-0043-112730.","journal-title":"Neurol Int Open"},{"key":"1447_CR23","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1212\/NXI.0000000000000658","volume":"7","author":"R Ruiz-Garc\u00eda","year":"2019","unstructured":"Ruiz-Garc\u00eda R, Mart\u00ednez-Hern\u00e1ndez E, Joubert B, Petit-Pedrol M, Pajar\u00f3n-Boix E, Fern\u00e1ndez V, Salais L, Del Pozo M, Armangu\u00e9 T, Sabater L, Dalmau J, Graus F. Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2. Neurol Neuroimmunol Neuroinflamm. 2019;7:e658. https:\/\/doi.org\/10.1212\/NXI.0000000000000658.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1447_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14802\/jmd.20040","volume":"14","author":"H Mitoma","year":"2021","unstructured":"Mitoma H, Manto M, Hadjivassiliou M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J Mov Disord. 2021;14:10\u201328.","journal-title":"J Mov Disord"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-022-01447-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-022-01447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T05:47:10Z","timestamp":1687931230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-022-01447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s12311-022-01447-8","relation":{},"ISSN":["1473-4230"],"issn-type":[{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"26 July 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}